188 related articles for article (PubMed ID: 17146441)
1. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K
Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441
[TBL] [Abstract][Full Text] [Related]
2. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.
Hart PJ; Deep S; Taylor AB; Shu Z; Hinck CS; Hinck AP
Nat Struct Biol; 2002 Mar; 9(3):203-8. PubMed ID: 11850637
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta control of cell proliferation.
Huang SS; Huang JS
J Cell Biochem; 2005 Oct; 96(3):447-62. PubMed ID: 16088940
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
[TBL] [Abstract][Full Text] [Related]
6. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro.
Mizuta H; Sanyal A; Fukumoto T; Fitzsimmons JS; Matsui N; Bolander ME; Oursler MJ; O'Driscoll SW
J Orthop Res; 2002 May; 20(3):562-74. PubMed ID: 12038632
[TBL] [Abstract][Full Text] [Related]
7. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.
Wang H; Liu J; Zong Y; Xu Y; Deng W; Zhu H; Liu Y; Ma C; Huang L; Zhang L; Qin C
Brain Res; 2010 Oct; 1357():166-74. PubMed ID: 20709030
[TBL] [Abstract][Full Text] [Related]
8. The novel type I serine-threonine kinase receptor Alk8 binds TGF-beta in the presence of TGF-betaRII.
de Caestecker MP; Bottomley M; Bhattacharyya S; Payne TL; Roberts AB; Yelick PC
Biochem Biophys Res Commun; 2002 May; 293(5):1556-65. PubMed ID: 12054694
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer.
Chen T; Carter D; Garrigue-Antar L; Reiss M
Cancer Res; 1998 Nov; 58(21):4805-10. PubMed ID: 9809982
[TBL] [Abstract][Full Text] [Related]
10. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB
J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420
[TBL] [Abstract][Full Text] [Related]
11. The TGF-beta type III receptor is localized to the medial edge epithelium during palatal fusion.
Cui XM; Shuler CF
Int J Dev Biol; 2000 Jun; 44(4):397-402. PubMed ID: 10949049
[TBL] [Abstract][Full Text] [Related]
12. Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors.
Yamada SD; Baldwin RL; Karlan BY
Gynecol Oncol; 1999 Oct; 75(1):72-7. PubMed ID: 10502429
[TBL] [Abstract][Full Text] [Related]
13. Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway.
Santander C; Brandan E
Cell Signal; 2006 Sep; 18(9):1482-91. PubMed ID: 16413747
[TBL] [Abstract][Full Text] [Related]
14. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
[TBL] [Abstract][Full Text] [Related]
15. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta.
Arandjelovic S; Freed TA; Gonias SL
Biochemistry; 2003 May; 42(20):6121-7. PubMed ID: 12755614
[TBL] [Abstract][Full Text] [Related]
16. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.
Thompson TB; Lerch TF; Cook RW; Woodruff TK; Jardetzky TS
Dev Cell; 2005 Oct; 9(4):535-43. PubMed ID: 16198295
[TBL] [Abstract][Full Text] [Related]
17. Albumin induces cellular fibrosis by upregulating transforming growth factor-beta ligand and its receptors in renal distal tubule cells.
Liu HC; Liao TN; Lee TC; Chuang LY; Guh JY; Liu SF; Hu MS; Yang YL; Lin SH; Hung MY; Huang JS; Hung TJ; Chen CD; Chiang TA; Chan JY; Chen SY; Yang YL
J Cell Biochem; 2006 Apr; 97(5):956-68. PubMed ID: 16267840
[TBL] [Abstract][Full Text] [Related]
18. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of transforming growth factor beta type II receptor mutants in human cancer.
De M; Yan W; de Jonge RR; Garrigue-Antar L; Vellucci VF; Reiss M
Cancer Res; 1998 May; 58(9):1986-92. PubMed ID: 9581843
[TBL] [Abstract][Full Text] [Related]
20. Scanning-deletion analysis of the extracellular domain of the TGF-beta receptor type II.
Pepin MC; Beauchemin M; Plamondon J; O'Connor-McCourt MD
Biochem Biophys Res Commun; 1996 Mar; 220(2):289-93. PubMed ID: 8645298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
